Fair value (multi-method)
Four independent methods triangulate what BMY is worth. The headline is the Forward-DCF intrinsic value at a normalized growth rate; the margin of safety compares it to the current price.
Estimated fair value (Forward DCF)
$195.03
Method range
$17.02 – $195.03
median $89.94
Valuation methods
Each method’s implied fair value per share and its upside versus the current price. Missing methods (no analyst coverage, negative earnings, etc.) are shown as “—”.
| Method | Fair value | Upside vs price |
|---|---|---|
| Forward DCF | $195.03 | +240.54% |
| Exit multiple | $118.16 | +106.32% |
| Analyst target | $61.73 | +7.79% |
| Graham number | $17.02 | -70.29% |
- Forward DCF$195.03
- Exit multiple$118.16
- Analyst target$61.73
- Graham number$17.02
Stock price
$57.27
FCF / share (TTM)
$0.37
3Y FCF CAGR
-1.9%
Fair value @ hist. growth
$7.83
This analysis is for informational purposes only and is not financial advice. Scenario prices and DCF-style figures depend on your assumptions and data from public filings and estimates. They are not forecasts of future returns.
Implied FCF growth
22.3%
per year over your projection horizon
Margin of safety -631.4% vs hist-growth DCF
Historical 3Y CAGR
-1.9%
Your model implies
22.3%
Analyst consensus is EPS-only — no comparable FCF / share estimate to show on this basis.
Model inputs
Move sliders to test how the reverse DCF reacts. Historical-growth markers show where the company has actually grown over the last cycle.
Undiscounted FCF per share over 10 years at -2% annual growth.
Sensitivity — implied growth vs your assumptions
Each cell shows the per-share growth rate the market would need to justify the current price at that combination of discount rate (rows) and terminal growth (columns). Your selected inputs are highlighted.
| Row axis: discount rate. Column axis: terminal growth.Terminal g →↓ Discount | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.0% | 22.0% | 20.2% | 18.2% | 15.8% | 12.7% |
| 5.0% | 22.0% | 20.2% | 18.2% | 15.8% | 12.7% |
| 5.8% | 25.3% | 23.9% | 22.3% | 20.5% | 18.4% |
| 6.8% | 28.7% | 27.6% | 26.4% | 25.0% | 23.4% |
| 7.8% | 31.8% | 30.9% | 29.8% | 28.7% | 27.4% |
Historical multiples
Each bar is the trailing five-year range (low left, high right). Filled portion runs from low to today; the dot marks today; the small tick marks the five-year median. Low, median, and high are listed under each bar.
PEG
0.08
Low vs growth
Net debt
$36.9B
Total debt − cash
Beta
0.26
Vs market benchmark
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation